IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis
Europe - BIT:IVG - NL0015000LU4 - Common Stock
18.29 EUR
0 (0%)
IVG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 103 industry peers in the Machinery industry. While IVG is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on IVG.
1. Profitability
1.1 Basic Checks
IVG had positive earnings in the past year.
IVG had a positive operating cash flow in the past year.
Of the past 5 years IVG 4 years were profitable.
In the past 5 years IVG always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of IVG (1.73%) is comparable to the rest of the industry.
With a decent Return On Equity value of 12.39%, IVG is doing good in the industry, outperforming 76.70% of the companies in the same industry.
The Return On Invested Capital of IVG (4.53%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for IVG is below the industry average of 8.77%.
The last Return On Invested Capital (4.53%) for IVG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROIC | 4.53% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
1.3 Margins
IVG has a Profit Margin (2.17%) which is in line with its industry peers.
In the last couple of years the Profit Margin of IVG has grown nicely.
IVG has a Operating Margin (5.00%) which is comparable to the rest of the industry.
IVG's Operating Margin has improved in the last couple of years.
The Gross Margin of IVG (16.49%) is worse than 89.32% of its industry peers.
IVG's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% |
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IVG is destroying value.
Compared to 1 year ago, IVG has less shares outstanding
IVG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IVG has an improved debt to assets ratio.
2.2 Solvency
IVG has an Altman-Z score of 1.76. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.76, IVG is in line with its industry, outperforming 44.66% of the companies in the same industry.
The Debt to FCF ratio of IVG is 14.82, which is on the high side as it means it would take IVG, 14.82 years of fcf income to pay off all of its debts.
IVG has a Debt to FCF ratio of 14.82. This is in the lower half of the industry: IVG underperforms 67.96% of its industry peers.
IVG has a Debt/Equity ratio of 1.35. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.35, IVG is not doing good in the industry: 84.47% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.66
WACC6.84%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IVG should not have too much problems paying its short term obligations.
IVG's Current ratio of 1.98 is fine compared to the rest of the industry. IVG outperforms 73.79% of its industry peers.
A Quick Ratio of 1.40 indicates that IVG should not have too much problems paying its short term obligations.
IVG's Quick ratio of 1.40 is fine compared to the rest of the industry. IVG outperforms 77.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
The earnings per share for IVG have decreased by -5.95% in the last year.
The Earnings Per Share has been growing by 32.82% on average over the past years. This is a very strong growth
Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -6.97% in the last year.
The Revenue has been growing slightly by 5.06% on average over the past years.
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
3.2 Future
The Earnings Per Share is expected to grow by 10.81% on average over the next years. This is quite good.
Based on estimates for the next years, IVG will show a small growth in Revenue. The Revenue will grow by 3.92% on average per year.
EPS Next Y-10.65%
EPS Next 2Y7.14%
EPS Next 3Y9.67%
EPS Next 5Y10.81%
Revenue Next Year-2.38%
Revenue Next 2Y2.68%
Revenue Next 3Y3.56%
Revenue Next 5Y3.92%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.58, the valuation of IVG can be described as very reasonable.
Based on the Price/Earnings ratio, IVG is valued cheaply inside the industry as 81.55% of the companies are valued more expensively.
IVG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.38.
With a Price/Forward Earnings ratio of 7.66, the valuation of IVG can be described as very cheap.
IVG's Price/Forward Earnings ratio is rather cheap when compared to the industry. IVG is cheaper than 90.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IVG to the average of the S&P500 Index (22.86), we can say IVG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.58 | ||
| Fwd PE | 7.66 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IVG is valued a bit cheaper than the industry average as 77.67% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IVG indicates a somewhat cheap valuation: IVG is cheaper than 70.87% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.4 | ||
| EV/EBITDA | 5.48 |
4.3 Compensation for Growth
The decent profitability rating of IVG may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.35
EPS Next 2Y7.14%
EPS Next 3Y9.67%
5. Dividend
5.1 Amount
IVG has a Yearly Dividend Yield of 1.80%. Purely for dividend investing, there may be better candidates out there.
IVG's Dividend Yield is a higher than the industry average which is at 2.88.
IVG's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IVG pays out 27.33% of its income as dividend. This is a sustainable payout ratio.
DP27.33%
EPS Next 2Y7.14%
EPS Next 3Y9.67%
BIT:IVG (9/19/2025, 7:00:00 PM)
18.29
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners41.97%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap4.96B
Analysts73.33
Price Target20.08 (9.79%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.8% |
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP27.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.8%
Min EPS beat(2)-15.44%
Max EPS beat(2)5.84%
EPS beat(4)3
Avg EPS beat(4)15.3%
Min EPS beat(4)-15.44%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)15.63%
EPS beat(12)8
Avg EPS beat(12)16.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-10.1%
Max Revenue beat(2)8.56%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-10.1%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.74%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.57%
PT rev (3m)13.14%
EPS NQ rev (1m)4.3%
EPS NQ rev (3m)3.19%
EPS NY rev (1m)-7.23%
EPS NY rev (3m)-7.23%
Revenue NQ rev (1m)1.67%
Revenue NQ rev (3m)-3.37%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-2.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.58 | ||
| Fwd PE | 7.66 | ||
| P/S | 0.33 | ||
| P/FCF | 12.4 | ||
| P/OCF | 3.85 | ||
| P/B | 1.91 | ||
| P/tB | 8.99 | ||
| EV/EBITDA | 5.48 |
EPS(TTM)1.58
EY8.64%
EPS(NY)2.39
Fwd EY13.05%
FCF(TTM)1.47
FCFY8.06%
OCF(TTM)4.75
OCFY25.98%
SpS54.61
BVpS9.58
TBVpS2.04
PEG (NY)N/A
PEG (5Y)0.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 12.39% | ||
| ROCE | 6% | ||
| ROIC | 4.53% | ||
| ROICexc | 5.79% | ||
| ROICexgc | 7.34% | ||
| OM | 5% | ||
| PM (TTM) | 2.17% | ||
| GM | 16.49% | ||
| FCFM | 2.7% |
ROA(3y)1.3%
ROA(5y)0.32%
ROE(3y)9.48%
ROE(5y)2.54%
ROIC(3y)3.91%
ROIC(5y)N/A
ROICexc(3y)4.85%
ROICexc(5y)N/A
ROICexgc(3y)5.77%
ROICexgc(5y)N/A
ROCE(3y)5.17%
ROCE(5y)N/A
ROICexcg growth 3Y26.65%
ROICexcg growth 5Y12.05%
ROICexc growth 3Y25.45%
ROICexc growth 5Y11.07%
OM growth 3Y29.77%
OM growth 5Y9.99%
PM growth 3Y77.09%
PM growth 5Y26.56%
GM growth 3Y7.43%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | 14.82 | ||
| Debt/EBITDA | 2.37 | ||
| Cap/Depr | 119.97% | ||
| Cap/Sales | 6% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 86.98% | ||
| Profit Quality | 124.22% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 1.76 |
F-Score6
WACC6.84%
ROIC/WACC0.66
Cap/Depr(3y)146.94%
Cap/Depr(5y)121.88%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.2%
Profit Quality(3y)212.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3Y88.31%
EPS 5Y32.82%
EPS Q2Q%-38.1%
EPS Next Y-10.65%
EPS Next 2Y7.14%
EPS Next 3Y9.67%
EPS Next 5Y10.81%
Revenue 1Y (TTM)-6.97%
Revenue growth 3Y6.52%
Revenue growth 5Y5.06%
Sales Q2Q%-3.52%
Revenue Next Year-2.38%
Revenue Next 2Y2.68%
Revenue Next 3Y3.56%
Revenue Next 5Y3.92%
EBIT growth 1Y-21.25%
EBIT growth 3Y38.23%
EBIT growth 5Y15.55%
EBIT Next Year76.38%
EBIT Next 3Y30.18%
EBIT Next 5YN/A
FCF growth 1Y-7.83%
FCF growth 3YN/A
FCF growth 5Y-8.52%
OCF growth 1Y-0.31%
OCF growth 3Y26.42%
OCF growth 5Y8.96%